GoodRx Holdings, Inc.
GDRX
$2.61
-$0.08-2.97%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -4.42% | -1.91% | 0.40% | 1.23% | 2.57% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -4.42% | -1.91% | 0.40% | 1.23% | 2.57% |
| Cost of Revenue | 50.82% | 43.23% | 14.85% | 12.47% | 7.19% |
| Gross Profit | -8.31% | -4.87% | -0.52% | 0.52% | 2.26% |
| SG&A Expenses | -1.72% | -5.21% | 0.05% | -6.44% | -7.04% |
| Depreciation & Amortization | 4.21% | 21.21% | 22.22% | 16.29% | 31.18% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.75% | -1.40% | 3.75% | -2.47% | -1.31% |
| Operating Income | -49.59% | -4.05% | -28.36% | 34.87% | 36.35% |
| Income Before Tax | -66.17% | 24.40% | -24.80% | 68.10% | 5,588.74% |
| Income Tax Expenses | -20.41% | 87.79% | 20.11% | 35.99% | 331.34% |
| Earnings from Continuing Operations | -89.42% | -19.51% | -71.78% | 91.86% | 1,195.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -89.42% | -19.51% | -71.78% | 91.86% | 1,195.34% |
| EBIT | -49.59% | -4.05% | -28.36% | 34.87% | 36.35% |
| EBITDA | -26.49% | 43.59% | -4.98% | 26.31% | 34.08% |
| EPS Basic | -88.32% | -10.17% | -69.23% | 102.25% | 1,219.23% |
| Normalized Basic EPS | -70.32% | 0.58% | -34.52% | 77.72% | 62.91% |
| EPS Diluted | -88.32% | -10.17% | -68.00% | 102.25% | 1,219.23% |
| Normalized Diluted EPS | -70.32% | 0.77% | -32.93% | 81.48% | 62.91% |
| Average Basic Shares Outstanding | -10.20% | -10.85% | -8.66% | -5.22% | -2.78% |
| Average Diluted Shares Outstanding | -10.07% | -11.16% | -10.47% | -7.17% | -2.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |